다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Global Blood Therapeutics Inc (GBT)
Global Blood Therapeutics Inc (GBT) 뉴스

GBT

Global Blood Therapeutics (GBT)

Global Blood Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:GBT

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/02/10	01:04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/17	21:34	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/07	05:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05:41	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05:38	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05:38	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05:38	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05:37	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05:37	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05:33	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05:28	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05:22	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/06	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/05	22:00	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:GBT	Global Blood Therapeutics Inc
2022/10/05	06:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GBT	Global Blood Therapeutics Inc

검색 관련기사 보기:NASDAQ:GBT

1 2 3 4 5 6 7 8 9 10 다음 >>

Local World Forwarders

Pacer Swan SOS Moderate ...

UBS Lux Fund Sol Factor ...

Spirits Time (PK)

LoopringCoin V2

New Energy Metals

Horizon Kinetics Blockch...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관